Latest News

Malaria in Cambodia on Sky and PBS News

Malaria in Cambodia on Sky and PBS News

Posted 16/01/2019

Malaria causes nearly half a million deaths worldwide every year. Ninety percent of them are in sub-Saharan Africa, where poor infrastructure limits delivery of drugs. But now there is worry that those drugs are losing effectiveness as disease strains become resistant. In this video, doctors in Northern Cambodia are trialling a new drug combination therapy in a bid to stop the spread of drug resistant strains of malaria.

Sir David Weatherall, 1933-2018

Sir David Weatherall, 1933-2018

Posted 18/12/2018

An inspiring doctor and scientist of great compassion and intellect, Sir David Weatherall died 8 Dec 2018. A Nuffield Professor of Medicine, founder of the MRC Weatherall Institute of Molecular Medicine and a member of Wellcome’s Board throughout the 1990s, Sir David was instrumental in the creation of MORU back in 1979. Here’s what Wellcome and the University of Oxford say about Sir David’s remarkable career.

After MQPH 2018, new collaborations to fight substandard meds

After MQPH 2018, new collaborations to fight substandard meds

Posted 21/11/2018

Over 200 delegates travelled from more than 50 countries to attend the first ever conference on Medicine Quality and Public Health (MQPH 2018) in Oxford from 23-28 Sept. The conference, at Keble College, brought together experts in pharmacy, public health, chemistry, law, sociology, governance and ethics, from medicines regulatory authorities, academia, pharmaceutical industry, NGOs, and international organisations. The many conference partners ...

The Fight Against Malaria Has Reached a Standstill

The Fight Against Malaria Has Reached a Standstill

Posted 20/11/2018

Progress against malaria has stalled, and the disease remains a significant threat to billions of people despite the expensive, decades-long efforts to contain it. In an encouraging development, MORU reported complete success in curing hundreds of patients in Southeast Asia with new three-drug combinations mixing fast-acting artemisinin with two longer-lasting drugs. It it hoped that triple therapy should become the standard for malaria treatment.

Study finds cardiovascular side effects rare with quinoline antimalarials; urges pharmacovigilance

Study finds cardiovascular side effects rare with quinoline antimalarials; urges pharmacovigilance

Posted 09/11/2018

A systematic review analyses the results of 177 trials conducted between 1982 and 2016, including 18,436 patients who underwent electrocardiographic evaluation during malaria clinical trials. Nick White and colleagues found that serious cardiovascular side effects, which include sudden cardiac death, are very rare in the treatment of malaria with quinoline antimalarials. The work emphasises the importance of continued pharmacovigilance with the increasing use of quinoline antimalarials in mass treatment strategies such as intermittent preventative treatment and mass drug administration.

Oxford retains top spot for medicine for eighth consecutive year

Oxford retains top spot for medicine for eighth consecutive year

Posted 09/11/2018

Oxford University has been ranked as the world's best institution for medical and health teaching and research in the Times Higher Education World University Rankings for the eighth consecutive year. This ranking is based on criteria measuring teaching, research, industry income, international outlook and citations. It was noted that both research and clinical trials are supported by our network of international research units in Africa and Asia.

Provide basic health services in villages to eliminate malaria, say researchers in Myanmar

Provide basic health services in villages to eliminate malaria, say researchers in Myanmar

Posted 26/10/2018

Bangkok (Thailand) 25 October 2018 – The incidence of malaria cases continued to drop dramatically in rural and remote Myanmar villages after community workers trained only to detect and treat malaria began providing basic health care as well as malaria services, say University of Oxford affiliated researchers. Adding the health services to malaria control benefitted the villagers access to health and improved malaria services – paving the way ...

Global Health by the Pint

Global Health by the Pint

Posted 24/10/2018

Come and meet us at the ASTMH conference, to enjoy science over a pint and bite to eat: Outbreaks, from Ebola to Zika on Mon 29th Oct. Mosquitoes, the most dangerous animals in the world on Tue 30th. Global health terror night: bats, mites and other creepy crawlies on Wed 31st. We will be at The Vintage, 3121 Magazine St, New Orleans, 7-9pm

Asian Sepsis Alliance inaugurated at MORU Bangkok

Asian Sepsis Alliance inaugurated at MORU Bangkok

Posted 11/10/2018

    On 4 Oct, the MORU Malaria Dept, in collaboration with the Global Sepsis Alliance (GSA), hosted the inaugural meeting of a proposed Asian Sepsis Alliance in Bangkok.  The meeting drew intensive care and infectious disease physicians from 9 Asian-Pacific countries (Thailand, Pakistan, India, Sri Lanka, Bangladesh, Malaysia, Singapore, China and Australia). GSA heads Profs Konrad Reinhart, Simon Finfer and Flavia Machado also attended, ...

Myanmar researchers awarded research grants

Myanmar researchers awarded research grants

Posted 12/09/2018

11 Sept 2018 – Dr Myo Maung Maung Swe (left), Clinical Researcher and DPhil student at MOCRU, was awarded in August an International Society for Infectious Diseases (ISID) research grant, a signature ISID program that funds infectious disease researchers from LMIC countries with the greatest burden of infectious disease. Myo Maung, a clinical researcher at MOCRU for 3 years, was awarded the ISID research grant to conduct the study Antibiotics ...